loading

Finanzdaten der Tonix Pharmaceuticals Holding Corp-Aktie (TNXP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
34.32%
2.482
3.779 3.989 - -
Operating Expenses
23.39%
23.83
31.11 32.14 - -
Benefits Costs and Expenses
24.57%
26.32
34.89 36.12 - -
Costs And Expenses
23.39%
23.83
31.11 32.14 29.00 33.90
Depreciation and Amortization
0.00%
1.00
1.00 0.978 - -
Operating Income/Loss
21.87%
-21.35
-27.33 -28.15 -29.00 -33.90
Income/Loss From Continuing Operations Before Tax
23.39%
-23.83
-31.11 -32.14 -28.36 -33.01
Income/Loss From Continuing Operations After Tax
45.32%
-14.94
-27.32 -27.98 -28.36 -33.01
Net Income/Loss
45.32%
-14.94
-27.32 -27.98 -28.36 -33.01
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,531%
80.88
4.9597 15.33 10.59 63.35
Diluted Average Shares
1,531%
80.88
4.9597 15.33 10.59 63.35
Basic Earnings Per Share
132.73%
-0.18
0.55 -1.83 -2.68 -0.52
Diluted Earnings Per Share
132.73%
-0.18
0.55 -1.83 -2.68 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.02
price up icon 2.14%
$18.21
price down icon 5.55%
$40.13
price down icon 0.74%
$359.96
price down icon 1.14%
$181.89
price down icon 1.51%
$113.95
price up icon 0.16%
Kapitalisierung:     |  Volumen (24h):